Gene therapy targeting telomeres shows promise in restoring cardiac function during heart failure progression.
Our work establishes the role of telomere-mitochondria DNA signaling during HF progression and provides proof-of-concept of telomere-targeting gene therapy to restore cardiac function.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: